Characteristics of patients with stage III and IV ovarian endometriomas and trends in postoperative anti-Mullerian hormone changes

INTRODUCTION: This study aimed to investigate the manifestations of postoperative Anti-Mullerian hormone (AMH) changes in patients with stage III and IV ovarian endometriomas. METHODS: Trends in postoperative AMH were categorized and described, and the risk factors for postoperative AMH decline were...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Kefei, Lian, Wenqin, Zhao, Rui, Xiong, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259385/
https://www.ncbi.nlm.nih.gov/pubmed/37313209
http://dx.doi.org/10.5114/aoms/162114
Descripción
Sumario:INTRODUCTION: This study aimed to investigate the manifestations of postoperative Anti-Mullerian hormone (AMH) changes in patients with stage III and IV ovarian endometriomas. METHODS: Trends in postoperative AMH were categorized and described, and the risk factors for postoperative AMH decline were screened using dichotomous logistic regression. RESULTS: The overall trend of postoperative AMH decreased, with a more significant decrease in stage IV than stage III cases. Elevated preoperative CA-125 levels, a history of caesarean section, and abortion were independent risk factors for postoperative AMH decline. CONCLUSIONS: There is a general trend toward decreasing AMH levels after surgery, but each case may also show a different elevation.

Ejemplares similares